Accueil   Diary - News   All news AAA Reports 37% growth in sales for the 3th quarter of 2015

AAA Reports 37% growth in sales for the 3th quarter of 2015

  • Reported an increase in year -over-year sales of approximately 37% for Q3 2015 compared toQ3 2014

 

  • Reported an increase in year-over-year sales of approximately 32% for the first nine months of 2015 compared to the first nine months of 2014

 

 

  • Announced positive results from Phase 3 NETTER-1 study, evaluating lead drug candidate Lutathera in patients with advanced midgut neuroendocrine tumors

 

  • Obtained two Marketing Authorizations in France for FCholine and FDopa

 

  • Received FDA Priority Review for Somakit-TATE New Drug Application

 

  • Submitted MA application to EMA for Somakit-TOC

 

 

 

Read the press release